Overview
Hikaru Kobayashi practices in Nagano, Japan. Kobayashi is highly rated in 10 conditions, according to our data. Their top areas of expertise are Angioimmunoblastic T-cell Lymphoma, Lymphofollicular Hyperplasia, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Their clinical research consists of co-authoring 135 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Kobayashi isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Angioimmunoblastic T-cell Lymphoma
- Bone Marrow AspirationKobayashi isAdvanced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantKobayashi isAdvanced. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)
- Hemolytic CrisisKobayashi isAdvanced. Learn about Hemolytic Crisis.
- Experienced
- Absence SeizureKobayashi isExperienced. Learn about Absence Seizure.
- Acquired Amegakaryocytic Thrombocytopenia
- Acute Interstitial PneumoniaKobayashi isExperienced. Learn about Acute Interstitial Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Kobayashi isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaKobayashi isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult T-Cell LeukemiaKobayashi isExperienced. Learn about Adult T-Cell Leukemia.